CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $297,289
- in 4 filings, $297K under 10b5-1 plans
Net −$197,958. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Korczynski Sherry Chief Commercial Officer | Option exercise 10b5-1 | +8,750 | $2.65 | $23K | 244,439 |
| 2026-09-09 | Korczynski Sherry Chief Commercial Officer | Sale 10b5-1 | −8,750 | $5.22 | $46K | 235,689 |
| 2026-09-09 | Korczynski Sherry Chief Commercial Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −8,750 | 26,250 | ||
| 2026-08-14 | Korczynski Sherry Chief Commercial Officer | Shares withheld for taxes | −2,714 | $4.25 | $12K | 235,689 |
| 2026-06-08 | Korczynski Sherry Chief Commercial Officer | Shares withheld for taxes | −2,714 | 238,403 | ||
| 2026-03-10 | Korczynski Sherry Chief Commercial Officer | Sale | −15,741 | $4.17 | $66K | 241,117 |
| 2026-03-09 | Korczynski Sherry Chief Commercial Officer | Grant or award | +75,000 | 256,858 | ||
| 2026-03-09 | Korczynski Sherry Chief Commercial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +42,500 | $4.29 | $182K | 42,500 |
| 2025-08-14 | Korczynski Sherry Chief Commercial Officer | Grant or award | +25,000 | 181,858 | ||
| 2025-06-09 | Korczynski Sherry SVP Sales and Marketing | Shares withheld for taxes | −2,714 | $3.54 | $10K | 156,858 |
| 2025-03-07 | Korczynski Sherry Chief Commercial Officer | Grant or award · Performance Stock Units | +67,500 | 67,500 | ||
| 2025-03-07 | Korczynski Sherry SVP Sales and Marketing | Grant or award | +90,000 | 165,000 | ||
| 2025-03-07 | Korczynski Sherry SVP Sales and Marketing | Shares withheld for taxes | −5,428 | $2.65 | $14K | 159,572 |
| 2025-03-07 | Korczynski Sherry SVP Sales and Marketing | Grant or award · Non-Qualified Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-07 | Korczynski Sherry SVP Sales and Marketing | Grant or award | +25,000 | 25,000 |
Page 1 of 1 · 15 trades